Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Revolution Medicines' pancreatic cancer drug Rasonque achieves an eye-popping commercial debut, shattering analyst estimates.
10 trends tracked about this subject — the full history, oldest to newest below.
Revolution Medicines' pancreatic cancer drug Rasonque achieves an eye-popping commercial debut, shattering analyst estimates.
Daraxonrasib enters clinical focus as a game-changing new treatment for metastatic pancreatic cancer.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The European Medicines Agency has fast-tracked the review of an experimental pancreatic cancer pill amid reports of significant clinical trial outcomes.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.